✦ LIBER ✦

Risk-Adapted Preemptive Therapy for Cytomegalovirus Diseases after Allogeneic Hematopoietic Stem Cell Transplantation

✍ Scribed by Takehiko Mori; Yoshinobu Aisa; Tomonori Nakazato; Yasuo Ikeda; Shinichiro Okamoto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk-Adapted Preemptive Therapy for Cyto

✍ Su-Mi Choi; Dong-Gun Lee; Jung-Hyun Choi; Jin-Hong Yoo; Yoo-Jin Kim; Sun Hee Par 📂 Article 📅 2005 🏛 Carden Jennings Publishing 🌐 English ⚖ 132 KB

Risk-Adapted Preemptive Therapy for Cyto

✍ Su-Mi Choi; Dong-Gun Lee; Jung-Hyun Choi; Jin-Hong Yoo; Yoo-Jin Kim; Sun Hee Par 📂 Article 📅 2006 🏛 Carden Jennings Publishing 🌐 English ⚖ 42 KB

A randomized trial of preemptive therapy

✍ Seung Tae Kim; Mark H. Lee; Sung Yong Kim; Seok Jin Kim; Dong Hwan Kim; Jun Ho J 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 207 KB

Preemptive Therapy for Cytomegalovirus D

✍ F. de la Cruz-Vicente; P. Cerezuela Martinez; E. Gil-Espárraga; C. Martin Aguile 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Risk Factors for Progression from Cytome

✍ Ji Eun Jang; Shin Young Hyun; Yun Deok Kim; Sul Hee Yoon; Doh Yu Hwang; Soo Jeon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Prevention of Cytomegalovirus Infection

✍ S. Mossad 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB